Skip to main content Skip to main menu
  • Accessibility
  • Visiting Fiocruz
  • Sitemap
  • Intranet
  • Português
  • English
  • Español

Fiocruz

Oswaldo Cruz Foundation an institution in the service of life

Search in Fiocruz

Início do menu principal
  • Início
  • The Foundation
  • Research and teaching
  • Production and innovation
  • Health services
  • Communication and information
  • Access to information
Início do conteúdo

You are here » Home » Production and innovation

Production and innovation

P
  • Vaccines
  • Medications
  • Reactives
  • Patents
  • Partnerships
  • Innovation Portfolio

One of Fiocruz’s main missions is manufacturing strategic products for the Brazilian Unified Public Health System (SUS). With one of the largest public pharmaceutical laboratories in the country - the Drug Technology Institute (Farmanguinhos) - Fiocruz contributes with nearly 40% of the drug purchased by the Ministry of Health from official laboratories, but accounts for only 5% of these expenditures. Farmanguinhos generates savings to the public coffers, especially because it masters production technologies for drugs used in AIDS treatment, allowing the government to regulate prices charged by other laboratories and even to determine compulsory licensing of  medicines, as occurred with Efavirenz, an antiretroviral.

Fiocruz has also one of Brazil’s largest public laboratories for vaccine production: the Immunobiological Technology Institute (Biomanguinhos), which manufactured nearly 130 million doses in 2008. Biomanguinhos is the world’s largest manufacturer of the vaccine against yellow fever, and the only Latin American laboratory certified by the World Health Organization (WHO) for this purpose. It also manufactures vaccines against polio, meningitis A and C, MMR, monovalent Hib and Hib+DTP. As of 2007, the latter started to be produced using 100% Brazilian technology. In addition to vaccines, Biomanguinhos annually produces about six million reagents for diagnosis of HIV-1, HIV-1 / 2, Chagas’ disease, dengue fever, leishmaniasis and leptospirosis.

Biological collections
Biological collections
Microbiological, zoological and histopathological categories
Immunobiological Technology Institute (Biomanguinhos)
Photo of medicines
The Institute guarantees brazilian self-sufficiency in essential vaccines demanded by brazilian vaccination schedule
Fiocruz Africa
Photo of the building of Fiocruz Africa
First international unit
Portfolio Innovation
Art over the design of the Portifolio Innovation' site

Back to the topBack

Image Fiocruz from A to Z

  • Access to genetic resources and associated traditional knowledge
  • Audiovisual
  • Biological Collections
  • History
  • Indexed scientific journals
  • Innovation Portfolio
  • Institutional profile
  • Institutional repository
  • Management of the Collections
  • Oswaldo Cruz
  • Partnerships
  • Press room
  • Quality Assurance
  • Reactive
  • Thesis and papers
  • Units and offices
  • Vaccines

Image Fiocruz from A to Z

Main Campus:
Av. Brazil, 4365 - Manguinhos, Rio de Janeiro - CEP:21040-900 - Phone:(0xx21)2598-4242

  • Índice alfabético
  • Expediente


Este portal é regido pela Política de Acesso Aberto ao Conhecimento, que busca garantir à sociedade o acesso gratuito, público e aberto ao conteúdo integral de toda obra intelectual produzida pela Fiocruz.


creative commons O conteúdo deste portal pode ser utilizado para todos os fins não comerciais, respeitados e reservados os direitos morais dos autores.






logo todo somos SUS Logo 120 anos Logo governo federal